A phosphatidylinositol 3-kinase inhibitor strongly suppressed pulmonary vascular remodeling of allergic vasculitis in a murine model

References

• Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999;111:507–513.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol. 1995;101(Suppl 1):18–22.
   PubMedGoogle Scholar
• Hellmich B, Gross WL: Recent progress in the pharmacotherapy of Churg–Strauss syndrome. Expert Opin Pharmacother. 2004;5:25–35.
   PubMed Web of Science ®Google Scholar
• Klion AD, Bochner BS, Gleich GJ, Nutman TB, Rothenberg ME, Simon HU, Wechsler ME, Weller PF. The Hypereosinophilic Syndromes Working Group: Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol. 2006;117:1292–1302.
   PubMed Web of Science ®Google Scholar
• Keogh KA, Specks U: Churg-Strauss syndrome: update on clinical, laboratory and therapeutic aspects. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:3–12.
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Sasaki N, Niisato M, Kamataki A, Shikanai T, Nakamura Y, Kobayashi H, Suwabe A, Kanno H, Sawai T, Inoue H. Analysis of pulmonary allergic vasculitis with eosinophil infiltration in asthma model of mice. Exp Lung Res. 2010;36:227–236.
   PubMed Web of Science ®Google Scholar
• Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol. 1999;11:219–225.
   PubMed Web of Science ®Google Scholar
• Anderson KE, Jackson SP. Class I phosphoinositide 3-kinases. Int J Biochem Cell Biol. 2003;35:1028–1033.
   PubMed Web of Science ®Google Scholar
• Kumar CC, Madison V. AKT crystal structure and AKT-specific inhibitors. Oncogene. 2005;24:7493–7501.
   PubMed Web of Science ®Google Scholar
• Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, Asano T, Takeuchi T, Kadowaki T, Hata J, Koyasu S. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K- deficient mice. Nat Immunol. 2002;3:295–304.
   PubMed Web of Science ®Google Scholar
• Palframan RT, Collins PD, Severs NJ, Rothery S, Williams TJ, Rankin SM. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med. 1988;188:1621–1632.
   PubMed Web of Science ®Google Scholar
• Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5:495–502.
   PubMed Web of Science ®Google Scholar
• Haruta K, Mori S, Tamura N, Sasaki A, Nagamine M, Yaguchi S, Kamachi F, Enami J, Kobayashi S, Yamori T, Takasaki Y. Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats. Inflamm Res. 2012;61:551–562.
   PubMed Web of Science ®Google Scholar
• Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood and bone marrow compartments in a murine model of allergen- induced airways inflammation. Am J Respir Cell Mol Biol. 1997;16:510–520.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Sasaki N, Utsumi Y, Nagashima H, Nakamura Y, Yamashita M, Yamauchi K, Sawai T: Effects of imatinib mesylate on pulmonary allergic vasculitis in a murine model. Int J Rheum Dis. 2013;16:455–462.
   PubMed Web of Science ®Google Scholar
• Koizumi R, Sasaki N, Nakamura Y, Suzuki N, Sawai T, Yamauchi K: Rapamycin attenuates pulmonary allergic vasculitis in murine model by reducing TGF-β production in the lung. Allergol Int. 2014;63:457–466.
   PubMed Web of Science ®Google Scholar
• Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med. 1997;186:1737–1747.
   PubMed Web of Science ®Google Scholar
• Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Haczku A, Gelfand EW, Leikauf GD, Lee NA: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 1997;185:2143–2156.
   PubMed Web of Science ®Google Scholar
• Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol. 2001;108:594–601.
   PubMed Web of Science ®Google Scholar
• Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, Hogan SP, Mahalingam S, Mckenzie AN, Rothenberg ME, Young IG, Matthaei KI, Webb DC. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev. 2001;179:173–181.
   PubMed Web of Science ®Google Scholar
• Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol. 2003;3:405–412.
   PubMed Web of Science ®Google Scholar
• Lim DH, Cho JY, Song DJ, Lee SY, Miller M, Broide DH. PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol. 2009;296:L210–L219.
   Google Scholar
• Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD: Inhibition of phosphoinositide 3-kinase delta attenuates allergic air-way inflammation and hyperresponsiveness in murine asthma model. FASEB J. 2006;20:455–465.
   PubMed Web of Science ®Google Scholar
• Raghow B, Irish P, Kang AH. Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest. 1989;84:1836–1842.
   PubMed Web of Science ®Google Scholar
• Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A. 1991;88:6642–6646.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.
   PubMed Web of Science ®Google Scholar
• Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP, Sime PJ. PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One. 2011;6:e15909.
   Google Scholar
• Le Cras TD, Korfhagen TR, Davidson C, Schmidt S, Fenchel M, Ikegami M, Whitsett JA, Hardie WD. Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol. 2010;176:679–686.
   PubMed Web of Science ®Google Scholar